Summary
The approval marks the second GLP-1 oral pill cleared in the UK after Novo Nordisk secured its nod for the Wegovy pill, intensifying competition between the two pharma majors.
Eli Lilly’s weight-loss pill secures first European nod in Britain
Source & full coverage: this summary is aggregated from Free Malaysia Today Business, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at Free Malaysia Today Business →
